Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
NF

NINIO FETALVO

MICHAEL BEST STRATEGIES LLC · Washington, DC
Registered · LDAActive

Background

Career
Washington, DC · current
Government experience
Dir of Strategic Communications
Deputy Dir of Communications, Centers for Medicare & Medicaid Services, U.S. Dept of Health & Human Services; Communications Advisor, Associate Advisor, Assistant Press Secretary, Executive Office of the President
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
19
past 12 months
Filings
21
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEExecutive Office of the President (EOP)Health & Human Services, Dept of (HHS)Commerce, Dept of (DOC)Treasury, Dept ofJustice, Dept of (DOJ)Office of Management & Budget (OMB)Agriculture, Dept of (USDA)Veterans Affairs, Dept of (VA)Defense, Dept of (DOD)Education, Dept ofEnergy, Dept ofEnvironmental Protection Agency (EPA)Federal Communications Commission (FCC)Food & Drug Administration (FDA)General Services Administration (GSA)Homeland Security, Dept of (DHS)Interior, Dept of (DOI)State, Dept of (DOS)Transportation, Dept of (DOT)U.S. Trade Representative (USTR)

Specific issues

Issues related to federal contracting
Disaster Planning/Emergencies · 2026 Q2
Issues related to natural resources and commodities trading
Natural Resources · 2026 Q2
Increase in the net investment income tax for certain foundations, Food is Medicine initiative with FDA and HHS.
Health Issues · 2026 Q1
H.R. 3816, Weather Act Reauthorization; access to important weather data from NOAA; role of private weather forecasting, S.3923, Weather Research and Forecasting Innovation Reauthorization Act of 2026.
Science/Technology · 2026 Q1
Issues pertaining to the reallocation of conservation funding, including the Land and Water Conservation Fund.
Environment/Superfund · 2026 Q1
Scientific innovation in healthcare including gene therapy, rare diseases including Duchenne muscular dystrophy
Health Issues · 2026 Q1

Clients

2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing · engagement ended
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing · engagement ended
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings14
2026 Q2
GIFT-IN-KIND MARKETPLACE
RRlda.gov →
2026 Q2
GLENCORE LIMITED
RRlda.gov →
2026 Q1
BIOWOUND SOLUTIONS
Q1lda.gov →
2026 Q1
SAREPTA THERAPEUTICS
Q1lda.gov →
2026 Q1
CVS HEALTH
Q1lda.gov →
2026 Q1
WILMERHALE ON BEHALF OF THE ROCKEFELLER FOUNDATION
Q1lda.gov →
2026 Q1
NORTHWELL HEALTH
Q1lda.gov →
2026 Q1
AMERICAN KRATOM ASSOCIATION
Q1lda.gov →
2026 Q1
FMC CORPORATION
Q1lda.gov →
2026 Q1
LIGHTSPEED VENTURE PARTNERS
Q1lda.gov →
2026 Q1
AMERICA'S HEALTH INSURANCE PLANS, INC.
Q1lda.gov →
2026 Q1
ACCESSO BIOLOGICS
Q1lda.gov →
2026 Q1
THE NATURE CONSERVANCY
1Tlda.gov →
2026 Q2
MCDONALDS CORPORATION
RRlda.gov →